Abstract
Objectives: Smartphone usage amongst clinicians is widespread. Yet smartphones are not widely used for the dissemination of policy or as clinical decision support systems. We report here on the development, adoption and implementation process of the Imperial Antimicrobial Prescribing Application across five teaching hospitals in London. Methods: Doctors and clinical pharmacists were recruited to this study, which employed a mixed methods in-depth case-study design with focus groups, structured pre- and post-intervention survey questionnaires and live data on application uptake. The primary outcome measure was uptake of the application by doctors and its acceptability. The development and implementation processes were also mapped. Results: The application was downloaded by 40% (376) of junior doctors with smartphones (primary target user group) within the first month and by 100% within 12 months. There was an average of 1900 individual access sessions per month, compared with 221 hits on the Intranet version of the policy. Clinicians (71%) reported that using the application improved their antibiotic knowledge. Conclusions: Clinicians rapidly adopted the mobile application for antimicrobial prescribing at the point of care, enabling the policy to reach a much wider audience in comparison with paper- and desktop-based versions of the policy. Organizations seeking to optimize antimicrobial prescribing should consider utilizing mobile technology to deliver point-of-care decision support. The process revealed a series of barriers, which will need to be addressed at individual and organizational levels to ensure safe and high-quality delivery of local policy at the point of care.
| Original language | English |
|---|---|
| Article number | dks492 |
| Pages (from-to) | 960-967 |
| Number of pages | 8 |
| Journal | Journal of Antimicrobial Chemotherapy |
| Volume | 68 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 1 Apr 2013 |
| Externally published | Yes |
Funding
The development of the IAPP was clinician-led and supported by the organizational hierarchy using resources from the academic research unit based at Imperial College, London. The IAPP was developed in iterative stages. We employed an in-depth case-study design, which involved both qualitative and quantitative methods of inquiry that informed each other and enabled triangulation of the findings.19 The selected design was appropriate to our study, which aimed to explore the technology journey in-depth and systematically search for potential risks and benefits to individuals and organizations during the implementation process. Ethical approval was obtained from the Imperial Joint Research Office, who confirmed that this work did not require submission to the Multi Centre Research Ethics Committee. This work is supported by the National Institute for Health Research Biomedical Research Centre Funding Scheme at Imperial College (funding number not applicable), the National Centre for Infection Prevention and Management (CIPM) funded by the United Kingdom Clinical Research Council (UKCRC G0800777) and the Showcase Hospitals Fund.
Keywords
- Antimicrobial management
- Decision support
- eHealth
- Technology adoption